Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMP) have been implicated in the pathology of Parkinson’s and Alzheimer’s diseases, where MMP can cleave amyloid beta [51]. The gene discussed is TIMP1; the disease is early-onset autosomal dominant Alzheimer disease.